These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30061618)

  • 1. Monitoring and detection of leprosy patients in Southwest China: A retrospective study, 2010-2014.
    Le W; Haiqin J; Danfeng H; Ying S; Wenyue Z; Jun Y; Li X; Tiejun S; Limei S; Jie L; De W; Yong N; Yangying L; Hao W; Yanfei K; Bin L; Maeda Y; Duthie M; Meiwen Y; Hongsheng W; Liangbin Y; Guocheng Z; Baoxi W; Heng G
    Sci Rep; 2018 Jul; 8(1):11407. PubMed ID: 30061618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of antibody detection against the NDO-BSA, LID-1 and NDO-LID antigens as confirmatory tests to support the diagnosis of leprosy in Yunnan province, southwest China.
    Jian L; Xiujian S; Yuangang Y; Yan X; Lianchao Y; Duthie MS; Yan W
    Trans R Soc Trop Med Hyg; 2020 Feb; 114(3):193-199. PubMed ID: 31667502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region.
    da Conceição Oliveira Coelho Fabri A; Carvalho AP; Araujo S; Goulart LR; de Mattos AM; Teixeira HC; Goulart IM; Duthie MS; Correa-Oliveira R; Lana FC
    BMC Infect Dis; 2015 May; 15():218. PubMed ID: 26021317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antigen-specific immune responses for leprosy diagnosis in a hyperendemic area in China.
    Chen X; You YG; Yuan YH; Yuan LC; Zhang Y; Yan W
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006777. PubMed ID: 30248098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil.
    Leturiondo AL; Noronha AB; do Nascimento MOO; Ferreira CO; Rodrigues FDC; Moraes MO; Talhari C
    BMC Infect Dis; 2019 Jan; 19(1):22. PubMed ID: 30616580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antibodies to both M. leprae PGL-I and MMP-II to recognize leprosy patients at an early stage of disease progression.
    Wang H; Liu W; Jin Y; Yu M; Jiang H; Tamura T; Maeda Y; Makino M
    Diagn Microbiol Infect Dis; 2015 Nov; 83(3):274-7. PubMed ID: 26320400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of immunoglobulin isotypes against LID-1 and NDO-LID for, particularly IgG1, confirming the diagnosis of multibacillary leprosy.
    Marçal PHF; Fraga LAO; Mattos AMM; Menegati L; Coelho ADCO; Pinheiro RO; Sarno EN; Duthie MS; Teixeira HC
    Mem Inst Oswaldo Cruz; 2018; 113(5):e170467. PubMed ID: 29513821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of an active surveillance strategy of targeting household and neighborhood  contacts related to leprosy cases released from treatment in a low-endemic area of China.
    Wang N; Chu T; Li F; Wang Z; Liu D; Chen M; Wang H; Niu G; Liu D; Zhang M; Xu Y; Zhang Y; Li J; Li Z; You J; Mao L; Li H; Chen Y; Liu H; Zhang F
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008563. PubMed ID: 32797081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of serological conversion as a risk factor for development of leprosy among household contacts.
    Douglas JT; Cellona RV; Fajardo TT; Abalos RM; Balagon MV; Klatser PR
    Clin Diagn Lab Immunol; 2004 Sep; 11(5):897-900. PubMed ID: 15358649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial and temporal epidemiology of Mycobacterium leprae infection among leprosy patients and household contacts of an endemic region in Southeast Brazil.
    Nicchio MV; Araujo S; Martins LC; Pinheiro AV; Pereira DC; Borges A; Antunes DE; Barreto JG; Goulart IM
    Acta Trop; 2016 Nov; 163():38-45. PubMed ID: 27469619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Immunodiagnostic Tests for Leprosy in Brazil, China and Ethiopia.
    van Hooij A; Tjon Kon Fat EM; Batista da Silva M; Carvalho Bouth R; Cunha Messias AC; Gobbo AR; Lema T; Bobosha K; Li J; Weng X; Salgado CG; Spencer JS; Corstjens PLAM; Geluk A
    Sci Rep; 2018 Dec; 8(1):17920. PubMed ID: 30560920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-PGL-I seroepidemiology in leprosy cases: household contacts and school children from a hyperendemic municipality of the Brazilian Amazon.
    Barreto JG; Guimarães Lde S; Leão MR; Ferreira DV; Lima RA; Salgado CG
    Lepr Rev; 2011 Dec; 82(4):358-70. PubMed ID: 22439276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent leprosy infection identified by dual RLEP and anti-PGL-I positivity: Implications for new control strategies.
    da Silva MB; Li W; Bouth RC; Gobbo AR; Messias ACC; Moraes TMP; Jorge EVO; Barreto JG; Filho FB; Conde GAB; Frade MAC; Salgado CG; Spencer JS
    PLoS One; 2021; 16(5):e0251631. PubMed ID: 33984058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel integrated molecular and serological analysis method to predict new cases of leprosy amongst household contacts.
    Gama RS; Souza MLM; Sarno EN; Moraes MO; Gonçalves A; Stefani MMA; Garcia RMG; Fraga LAO
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007400. PubMed ID: 31181059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leprosy surveillance study in a highly endemic Brazilian area using leprosy specific serologic tests and IFNγ whole blood assay.
    do Carmo Gonçalves A; Hungria EM; Freitas AA; Sékula-Bührer S; Gomes CM; Coelho AC; Nascimento LB; de Araújo Stefani MM
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2345-2360. PubMed ID: 32666479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
    Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal-spatial distribution characteristics of leprosy: A new challenge for leprosy prevention and control in Zhejiang, China.
    Wu L; Shen Y; Yao Q; Sang X; Fei L; Kong W; Huang Y; Wang Y; Zeng F; Du N
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008956. PubMed ID: 33411800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
    Richardus RA; van der Zwet K; van Hooij A; Wilson L; Oskam L; Faber R; van den Eeden SJF; Pahan D; Alam K; Richardus JH; Geluk A
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006083. PubMed ID: 29228004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with anti-phenolic glycolipid-I seropositivity among the household contacts of leprosy cases.
    Carvalho AP; da Conceição Oliveira Coelho Fabri A; Corrêa Oliveira R; Lana FC
    BMC Infect Dis; 2015 May; 15():219. PubMed ID: 26024906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
    Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.